NeuroOne Medical Technologies Corp. (NMTC)
0.8325
+0.04
(+5.38%)
USD |
NASDAQ |
Mar 05, 16:00
0.837
0.00 (0.00%)
After-Hours: 20:00
NeuroOne Medical Technologies Cash from Investing (Quarterly) : -0.0408M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zimmer Biomet Holdings, Inc. | -322.00M |
| Artivion, Inc. | -30.51M |
| Edwards Lifesciences Corp. | -198.30M |
| PetVivo Holdings, Inc. | 0.0051M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.116M |
| Cash from Financing (Quarterly) | 0.1478M |
| Free Cash Flow | -6.266M |
| Free Cash Flow Per Share (Quarterly) | -0.0627 |
| Free Cash Flow to Equity (Quarterly) | -3.127M |
| Free Cash Flow to Firm (Quarterly) | -3.157M |
| Free Cash Flow Yield | -16.72% |